Robertson H. Gilliland
CIK: 0001718351
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADIL
ADIAL PHARMACEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
About Gilliland Robertson H.
Gilliland Robertson H. (SEC CIK 0001718351) files insider reports with the SEC as Director of ADIAL PHARMACEUTICALS, INC. (ADIL).
Signal8 holds 2 ownership filings by Gilliland Robertson H., all Form 4s, filed between Jun 2, 2025 and Apr 9, 2026. Those filings report 2 transactions, from May 29, 2025 to Apr 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gilliland Robertson H.'s filings is in GLEN ALLEN, VA.
Recent filings by Gilliland Robertson H.
Other insiders filing for ADIAL PHARMACEUTICALS, INC. (ADIL)
- Davidson Matt, President and CEO
- Saiki Julie, Chief Strategy Officer
- Economides Vassiliki, Chief Financial Officer
- Young Wendy B., Director
- Coastlands Capital LP, 10% Owner
- Goodman Tony, Chief Operating Officer